Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IB/II study of alpelisib in combination with paclitaxel in patients with PIK3CA-altered metastatic/recurrent gastric cancer
KCT0005467Phase 2Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of alpelisib in gastric cancer (GC), sponsored by Seoul National University Bundang Hospital. Started Dec 2020; status: completed.
02
Drugs
alpelisib
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0005467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0005467.